A study published in the New England Journal of Medicine says patients with abdominal aortic aneurysms--a deadly weakening in the blood vessel that fuels the lower half of the body--are most likely to live and quickly recover if they are treated with stents instead of surgery. That's good news for Medtronic Inc., which is one of the leading makers of aortic stents.